They won’t. Unless COVID makes a massive resurgence in Australia (unlikely at present) or they get it off the ground in the UK or USA, it will be another cellularity MOU........MIA. I don’t view this ethics approval as a serious attempt.... unless they can expand it to non COVID ARDS patients? Which would be the obvious and more rewarding route.
Ann: Ethics Approval to Commence Clinical Trial in COVID-19, page-75
-
- There are more pages in this discussion • 200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 10159 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |